CoChat

Renal function during long-term lithium treatment: a cross-sectional and longitudinal study

Open access
Bocchetta, Alberto, Ardau, Raffaella, Fanni, Tiziana, Sardu, Claudia, Piras, Doloretta, Pani, Antonello, Del Zompo, Maria · 2015 · BMC Medicine

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The effects of lithium treatment on renal function have been previously shown, albeit with discrepancies regarding their relevance. In this study, we examined glomerular filtration rate in patients treated with lithium for up to 33 years. METHODS: All lithium patients registered from 1980 to 2012 at a Lithium Clinic were screened. Estimated glomerular filtration rate (eGFR) was calculated from serum creatinine concentration using the Modification of Diet in Renal Disease Study Group equation. A cross-sectional evaluation of the last available eGFR of 953 patients was carried out using multivariate regression analysis for gender, current age, and duration of lithium treatment. Survival analysis was subsequently applied to calculate the time on lithium needed to enter the eGFR ranges 45 to 59 mL/min/1.73 m² (G3a) or 30 to 44 mL/min/1.73 m² (G3b). Finally, 4-year follow-up of eGFR was examined in subgroups of patients who, after reduction to an eGFR lower than 45 mL/min/1.73 m² either i) continued lithium at the same therapeutic range or ii) discontinued lithium or continued at concentrations below the therapeutic range (0.5 mmol/L). RESULTS: In the cross-sectional evaluation, eGFR was found to be lower in women (by 3.47 mL/min/1.73 m²), in older patients (0.73 mL/min/1.73 m² per year of age), and in patients with longer lithium treatment (0.73 mL/min/1.73 m² per year). Half of the patients treated for longer than 20 years had an eGFR lower than 60 mL/min/1.73 m². The median time on lithium taken to enter G3a or G3b was 25 years (95% CI, 23.2-26.9) and 31 years (95% CI, 26.6-35.4), respectively. Progression of renal failure throughout the 4-year follow-up after a reduction to an eGFR lower than 45 mL/min/1.73 m² did not differ between the subgroup who continued lithium as before and the subgroup who either discontinued lithium or continued at concentrations below the therapeutic range. CONCLUSIONS: Duration of lithium treatment is to be added to advancing age as a risk factor for reduced glomerular filtration rate. However, renal dysfunction tends to appear after decades of treatment and to progress slowly and irrespective of lithium continuation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-014-0249-4

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Last available estimated glomerular filtration rate by current age and duration of lithium treatment in 953 patients.
Figure 1 Last available estimated glomerular filtration rate by current age and duration of lithium treatment in 953 patients.CC BY · PubMed Central
Figure 2 Prevalence of patients falling into different estimated glomerular filtration rate (eGFR) categories among subgroups exposed to lithium for different times. The last two available eGFR values were used to assign patients to the following eGFR categories: G1, both values higher than 89 mL/min/1.73 m2; G1/G2, one value within G1 and one within G2; G2, both values between 60 and 89 mL/min/1.73 m2; G2/G3a, one value within G2 and one within G3a; G3a, both values between 45 and 59 mL/min/1.73 m2; G3b–G5, both values lower than 44 mL/min/1.73 m2.
Figure 2 Prevalence of patients falling into different estimated glomerular filtration rate (eGFR) categories among subgroups exposed to lithium for different times. The last two available eGFR values were used to assign patients to the following eGFR categories: G1, both values higher than 89 mL/min/1.73 m2; G1/G2, one value within G1 and one within G2; G2, both values between 60 and 89 mL/min/1.73 m2; G2/G3a, one value within G2 and one within G3a; G3a, both values between 45 and 59 mL/min/1.73 m2; G3b–G5, both values lower than 44 mL/min/1.73 m2.CC BY · PubMed Central
Figure 3 Kaplan-Meier curve showing years on lithium treatment taken to enter stage G3a (45 to 59 mL/min/1.73 m 2 ; 136 events out of 953 patients; 1- to 33-year follow-up).
Figure 3 Kaplan-Meier curve showing years on lithium treatment taken to enter stage G3a (45 to 59 mL/min/1.73 m 2 ; 136 events out of 953 patients; 1- to 33-year follow-up).CC BY · PubMed Central
Figure 4 Kaplan-Meier curve showing years on lithium treatment taken to enter stage G3b (30 to 44 mL/min/1.73 m 2 ; 68 events out of 953 patients; 1- to 33-year follow-up).
Figure 4 Kaplan-Meier curve showing years on lithium treatment taken to enter stage G3b (30 to 44 mL/min/1.73 m 2 ; 68 events out of 953 patients; 1- to 33-year follow-up).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.

Cited by

See all 79

Metadata

Authors
Bocchetta, A., Ardau, R., Fanni, T., Sardu, C., Piras, D., Pani, A., & Del Zompo, M.
Affiliations
  • University of Cagliari (IT)
  • Azienda Ospedaliero-Universitaria Cagliari (IT)
  • Azienda Ospedaliera G. Brotzu (IT)
Corresponding author
Bocchetta, Alberto
Venue
BMC Medicine
Published
2015-01-21
Volume
13
Issue
1
Pages
12-12
ISSN
1741-7015 (ISSN-L)
OpenAlex
W1985028928
Cited by
77
References
30
Citations by year
2026: 5 · 2025: 2 · 2024: 8 · 2023: 6 · 2022: 10 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 10 · 2017: 12 · 2016: 9 · 2015: 4
FWCI
9.46
Type
journal article
Language
en
Open access
Locations
  • BMC Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
lithium, glomerular filtration rate, renal function, long-term lithium therapy, chronic kidney disease, renal failure, age as risk factor, bipolar disorder, estimated glomerular filtration rate, serum creatinine, lithium nephrotoxicity
MeSH terms
Adolescent, Adult, Age Factors, Aged, Creatinine, Cross-Sectional Studies, Female, Glomerular Filtration Rate, Humans, Lithium, Longitudinal Studies, Male, Middle Aged, Risk Factors, Antipsychotic Agents, Disease Progression, Renal Insufficiency, Chronic, Renal Insufficiency, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. https://app.cochat.ai/papers/10.1186/s12916-014-0249-4
The paper
Bocchetta, A., Ardau, R., Fanni, T., Sardu, C., Piras, D., Pani, A., & Del Zompo, M. (2015). Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. BMC Medicine. https://doi.org/10.1186/s12916-014-0249-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.